The cherished principles governing the publication of academic science haven’t changed in a hundred years, with concept of peer review at its core – but this ancient system is failing, with catastrophic consequences for life science innovators and investors alike. It might serve academia well enough, but they are not the only constituency who rely on the publicly funded body of knowledge that is the scientific literature. Commercial innovation in the life sciences has its foundations in the public knowledge base – and the needs of these innovators, the people who convert knowledge into products that benefit us all, are no longer being served by the current system. It is time to demand a change.
Prospect Venture Partners surprised the sector with its …
More
RxCelerate Ltd is an outsourced drug development platform based near Cambridge, UK. We specialize in delivering an entire road map of drug development services from discovery and medicinal chemistry through to formal preclinical development and clinical up to Phase IIa. In the last five years, we have witnessed dramatic changes in the drug development …
